IPIC Message Board - Msg: 7176432

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: muddphudd who wrote (1290)	1/8/1999 3:23:00 PM
From: Rambi	Read Replies (2) of 1359

THe move began two days ago--I just assumed it had something to do with this announcement: Interneuron Receives Milestone Payment From Lilly Payment Related to 1997 License for Development of Prozac for PMS LEXINGTON, Mass.--(BW HealthWire)--Jan. 6, 1999--Interneuron Pharmaceuticals, Inc. (NASDAQ:IPIC - news) today announced that it has received a milestone payment from Eli Lilly and Company [NYSE:LLY - news] in connection with a June 1997 license agreement between the companies related to the development of Prozac® (fluoxetine hydrochloride) for the treatment of premenstrual syndrome (PMS). The milestone payment marks the completion of a clinical trial with Prozac for the treatment of PMS. The 1997 agreement provided Lilly with U.S. and global patent application rights covering the use of Prozac for the treatment of PMS. Interneuron already has received up front fees from Lilly based on the license agreement and could receive future payments and royalties, if additional milestones are met. Other than that--dunno! But it's fine with me!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next